Picture of Eli Lilly and logo

LLY — Eli Lilly and News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Lilly Q3 Adjusted EPS USD 7.48 Vs. IBES Estimate USD 6.49




BRIEF-Lilly Q3 Adjusted EPS USD 7.48 Vs. IBES Estimate USD 6.49


Oct 29 (Reuters) - Lilly Q3 revenue USD 24,397 million vs. IBES estimate USD 22,610 million.

  • Q3 EPS USD 7.22
  • Q3 Mounjaro revenue USD 10,723 million
  • Q3 Zepbound revenue USD 5,352 million

Recent news on Eli Lilly and

See all news